Keywords: dendreon, posts, strong, results, provenge, combination, therapy

Dendreon posts strong results for Provenge combination therapy

Article | 07 March 2005

Print This

US cancer specialist biotechnology group Dendreon has revealed strong results from a Phase II study of its experimental vaccine Provenge. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in